OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Respiratory and Critical Care Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Long-Term Antibiotics in Bronchiectasis	62
Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension	55
Improving Medication Adherence in Asthma	43
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens	41
Sleep, Circadian Rhythms, and Lung Cancer	39
Mechanical Ventilation for COVID-19 Patients	38
Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis	33
Primary Ciliary Dyskinesia	31
Severe Infections Due to Respiratory Viruses	29
	28
Nonmalignant Pleural Effusions	28
Impact of Marijuana Use on Lung Health	26
Advances in the Understanding and Management of Chronic Obstructive Pulmonary Disease	19
Lung Transplant for Chronic Obstructive Pulmonary Disease	18
Prevention of Aspiration: Oral Care, Antibiotics, Others	17
Pseudomonas aeruginosa in Bronchiectasis	16
The Lung Allocation Score and Its Relevance	14
Imaging in the Intensive Care Unit	14
Chronic Obstructive Pulmonary Disease and Work: The Continuing Narrative	14
Antibiotic Strategies for Severe Community-Acquired Pneumonia	13
Indwelling Pleural Catheter: Management of Complications	13
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection	13
COVID-19-Related Pleural Diseases	12
Chronic Pulmonary Aspergillosis: Clinical Presentation and Management	12
Deployment-Related Respiratory Disease: Where Are We?	12

	11
Any Role of High-Dose Vitamin C for Septic Shock in 2021?	11
Definition and Epidemiology of Sepsis	11
The Oral–Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease	11
Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis	11
Update on Sepsis Epidemiology in the Era of COVID-19	11
	11
Pulmonary Physiology and Medicine of Diving	11
Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases	11
Tissue Perfusion and Diffusion and Cellular Respiration: Transport and Utilization of Oxygen	10
Management of Pulmonary Hypertension Associated with Chronic Lung Disease	10
Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care	10
Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease Overlap Syndrome	10
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia	10
Understanding the Updates in the Asthma Guidelines	9
Work-Related Sleep Disorders: Causes and Impacts	9
Blood Gas Transport: Implications for O2 and CO2 Exchange in Lungs and Tissues	9
Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies	8
How to Survive Sepsis: Patient Testimonial	8
Common Variable Immunodeficiency and Other Immunodeficiency Syndromes in Bronchiectasis	8
Malignant Central Airway Obstruction: What's New?	8
Bronchoscopic Lung Volume Reduction: A Review	8
Acute Rejection in the Modern Lung Transplant Era	8
Evidence for the Application of Sepsis Bundles in 2021	8
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease	8
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients	8
Interstitial Lung Disease Associated with Systemic Sclerosis	7
Management of Acutely Decompensated Pulmonary Hypertension	7
Life-Threatening Infections: Pulmonary and Systemic Infections	7
Community-Acquired Pneumonia: Postpandemic, Not Post-COVID-19	7
Intra-abdominal Infections	7
The Deteriorating Patient: Therapies Including Lung Transplantation	7
Bronchiectasis Exacerbations: Definitions, Causes, and Acute Management	7
Clinical Features of COVID-19 and Differentiation from Other Causes of CAP	7
Comorbid Insomnia and Sleep Apnea (COMISA): from research to clinical practice	7
Arterial Blood Gases and Acid–Base Regulation	7
Aspergillus and the Lung	7
	6
Pulmonary Hypertension Associated with Left Heart Disease	6
Early Diagnosis of Sepsis: The Role of Biomarkers and Rapid Microbiological Tests	6
Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management	6
Use of Antiviral Agents and other Therapies for COVID-19	6
Pathological Diagnosis of Pulmonary Aspergillosis	6
Severe Community-Acquired Pneumonia	6
Severe Community-Acquired Pneumonia in Immunocompromised Patients	6
HIV and COVID-19 Disease	6
Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia	6
Control of Breathing	6
Sleep and Circadian-Related Outcomes after Critical Illness	6
Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis	6

“Long Haulers”	6
Aspiration Pneumonia: Preface	6
Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias	6
Imaging in Asthma Management	6
Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy	6
Defining Clinical and Microbiological Nonresponse in Ventilator-Associated Pneumonia	6